Download Citation
Article Source:
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
Leroux-Roels G,
Maes C,
Clement F,
van Engelenburg F,
van den Dobbelsteen M,
et al.
(2013)
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
PLOS ONE 8(2): e55438.
https://doi.org/10.1371/journal.pone.0055438